Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Lejeune

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|January 1, 1975
Role of macrophages in immunity, with special reference to tumour immunology. A reviewF J Lejeune
Acta Chirurgica Belgica|December 12, 1997
The management of malignant melanoma revisitedF J Lejeune
Bruxelles Medical|August 1, 1978
[Is immunotherapy a weapon in the treatment of solid neoplastic tumors?]F J Lejeune
Current Opinion in Oncology|April 1, 1990
Surgery and radiotherapy for melanoma and skin neoplasmsF J Lejeune
Bulletin Du Cancer|February 25, 1999
[Melanoma update]F J Lejeune
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 5, 2005
What is the impact of sentinel node biopsy in the management of cancer?F J Lejeune
Bruxelles Medical|September 1, 1978
[Nevus and malignant melanoma]F J Lejeune
European Journal of Cancer (Oxford, England : 1990)|June 1, 1995
High dose recombinant tumour necrosis factor (rTNF alpha) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancerF J Lejeune
The Yale Journal of Biology and Medicine|December 1, 1973
Harding-Passey melanoma in the BALB-C mouse as a model for studying the interactions between host macrophages and tumor cellsF J Lejeune
Anticancer Research|July 1, 1987
Phase III adjuvant studies in operable malignant melanoma (review)F J Lejeune
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|January 1, 1975
Role of macrophages in immunity, with special reference to tumour immunology. A reviewF J Lejeune
Acta Chirurgica Belgica|December 12, 1997
The management of malignant melanoma revisitedF J Lejeune
Bruxelles Medical|August 1, 1978
[Is immunotherapy a weapon in the treatment of solid neoplastic tumors?]F J Lejeune
Current Opinion in Oncology|April 1, 1990
Surgery and radiotherapy for melanoma and skin neoplasmsF J Lejeune
Bulletin Du Cancer|February 25, 1999
[Melanoma update]F J Lejeune
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 5, 2005
What is the impact of sentinel node biopsy in the management of cancer?F J Lejeune
Bruxelles Medical|September 1, 1978
[Nevus and malignant melanoma]F J Lejeune
European Journal of Cancer (Oxford, England : 1990)|June 1, 1995
High dose recombinant tumour necrosis factor (rTNF alpha) administered by isolation perfusion for advanced tumours of the limbs: a model for biochemotherapy of cancerF J Lejeune
The Yale Journal of Biology and Medicine|December 1, 1973
Harding-Passey melanoma in the BALB-C mouse as a model for studying the interactions between host macrophages and tumor cellsF J Lejeune
Anticancer Research|July 1, 1987
Phase III adjuvant studies in operable malignant melanoma (review)F J Lejeune
Pageof 10